Review of Bone Modifying Agents in Metastatic Breast Cancer

Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related events (SREs) associated with metastatic breast canc...

Full description

Saved in:
Bibliographic Details
Published in:Cureus
Main Authors: Raghu Subramanian, Charumathi, Talluri, Swapna, Mullangi, Sanjana, Lekkala, Manidhar R, Moftakhar, Bahar
Format: Artigo
Language:Inglês
Published: Cureus 2021
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960030/
https://ncbi.nlm.nih.gov/pubmed/33738175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13332
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items